MX169205B - Composicion para estimular el crecimiento del cabello - Google Patents

Composicion para estimular el crecimiento del cabello

Info

Publication number
MX169205B
MX169205B MX011430A MX1143088A MX169205B MX 169205 B MX169205 B MX 169205B MX 011430 A MX011430 A MX 011430A MX 1143088 A MX1143088 A MX 1143088A MX 169205 B MX169205 B MX 169205B
Authority
MX
Mexico
Prior art keywords
composition
hair growth
stimulate hair
ghl
methods
Prior art date
Application number
MX011430A
Other languages
English (en)
Inventor
Loren Ralph Pickart
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Publication of MX169205B publication Critical patent/MX169205B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

La presente invención se refiere a una composición para estimular el crecimiento del cabello caracterizada porque comprende un derivado de GHL-Cu que tiene la fórmula general: (glicil-L-histidil-L-lisina-C-R): cobre (II) en donde R se selecciona del grupo que consiste de fracciones alquilo que contienen de 1 a 18 átomos de carbono, fracciones arilo que contienen de 6 a 12 átomos de carbono y fracciones alcoxi que contienen de 1 a 18 átomos de carbono, y fracciones ariloxi que contienen de 6 a 12 átomos de carbono, o en donde R es L-prolil-L-valil-L-fenilalanil-L-valina o L-valil-L-fenilalanil-L-valina. para usarse en la estimulación del crecimiento de cabello en animales de sangre caliente.
MX011430A 1987-05-11 1988-05-11 Composicion para estimular el crecimiento del cabello MX169205B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4844487A 1987-05-11 1987-05-11

Publications (1)

Publication Number Publication Date
MX169205B true MX169205B (es) 1993-06-24

Family

ID=21954621

Family Applications (1)

Application Number Title Priority Date Filing Date
MX011430A MX169205B (es) 1987-05-11 1988-05-11 Composicion para estimular el crecimiento del cabello

Country Status (11)

Country Link
US (1) US5135913A (es)
EP (1) EP0314755B1 (es)
JP (2) JP2604457B2 (es)
KR (1) KR960014776B1 (es)
AT (1) ATE110255T1 (es)
CA (1) CA1323839C (es)
DE (1) DE3851203T2 (es)
DK (1) DK10389A (es)
MX (1) MX169205B (es)
NO (1) NO175616C (es)
WO (1) WO1988008695A1 (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
EP0420914B1 (en) * 1988-06-16 1994-03-09 Procyte Corporation Cosmetic and skin treatment compositions
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5252559A (en) * 1991-08-20 1993-10-12 The Procter & Gamble Company His-Gly-Gly peptide and derivatives thereof for hair growth
EP1433477B1 (en) * 1992-07-13 2007-06-27 Shiseido Company, Ltd. Stabilised external skin treatment composition comprising retinol
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
DE69310339T2 (de) 1993-02-19 1997-08-21 Howard Green Präparate, die Corneozyt Proteine enthalten
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
CA2186448A1 (en) * 1994-03-28 1995-10-05 Loren R. Pickart Starch-metal complexes for skin and hair
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
US5735212A (en) * 1994-08-09 1998-04-07 Baldwin-Japan Ltd. Cylinder cleaning apparatus
US6001812A (en) * 1995-04-28 1999-12-14 Societe L'oreal S.A. Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US5614489A (en) * 1995-05-25 1997-03-25 Mohammadi; Fatemeh Method and composition for treating the skin
US5866142A (en) * 1995-07-20 1999-02-02 Riordan; Neil H. Skin treatment system
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
EP1054998A1 (en) 1998-01-20 2000-11-29 Pericor Science, Inc. Transglutaminase linkage of agents to tissue
WO1999045976A1 (en) * 1998-03-12 1999-09-16 The Procter & Gamble Company Proton donating actives in absorbent articles
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
CA2385551A1 (en) 1999-10-01 2001-04-12 Dmi Biosciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
KR100688910B1 (ko) * 2000-07-06 2007-03-08 주식회사 코리아나화장품 트리펩타이드 함유 립스틱 조성물
US20030166510A1 (en) * 2000-10-11 2003-09-04 Pickart Loren R. Methods and compositions for increasing skin remodeling
FR2826581B1 (fr) * 2001-06-29 2005-10-07 Oreal Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
FR2826580B1 (fr) * 2001-06-29 2005-09-30 Oreal Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
CA2462791A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
EP1434563A1 (en) * 2001-10-05 2004-07-07 Procyte Corporation Methods for the treatment of hyperpigmentation of skin
US20030148927A1 (en) * 2001-10-05 2003-08-07 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
JP2006504448A (ja) * 2002-07-02 2006-02-09 プロサイト コーポレイション ペプチド銅錯体および軟組織充填物を含有する組成物
WO2004014413A1 (en) * 2002-07-31 2004-02-19 Procyte Corporation Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
US7128923B2 (en) 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) * 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
FR2857667B1 (fr) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
FR2857597B1 (fr) * 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
US7737179B2 (en) * 2003-08-04 2010-06-15 J&J Consumer Companies, Inc. Methods for treatment of dermatological conditions
US20050260275A1 (en) * 2004-04-01 2005-11-24 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
WO2006023465A1 (en) * 2004-08-18 2006-03-02 Procyte Corporation Polyethylene glycol-peptide copper complexes and compositions and methods related thereto
CA2587036C (en) 2004-11-09 2014-07-08 The Cupron Corporation Methods and materials for skin care
US20060216258A1 (en) 2005-03-24 2006-09-28 Singleton Laura C Water-in-silicone emulsion compositions
DE102005026069A1 (de) * 2005-06-07 2006-12-14 Goldschmidt Gmbh Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
WO2008027984A1 (en) 2006-08-29 2008-03-06 Isolagen Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2065029B1 (en) 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
EP2542209A1 (en) 2010-03-01 2013-01-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
KR20150009521A (ko) * 2012-03-07 2015-01-26 파이브로셀 테크놀로지스, 인코퍼레이티드 국소피부제제 및 개인맞춤형 피부치료방법
TWI444197B (zh) * 2012-04-26 2014-07-11 Univ China Medical 用於改善皮膚老化之組合物
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use
US3832338A (en) * 1972-03-23 1974-08-27 Diagnostic Data Inc Orgotein production using a buffer solution containing divalent metal salts
US4022888A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
DE2700043C2 (de) * 1977-01-03 1983-12-08 Thera Gesellschaft für Patentverwertung mbH, 8036 Herrsching Mittel zur Verbesserung der Durchblutung und Wundheilung
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue
US4287184A (en) * 1977-11-23 1981-09-01 The Massachusetts General Hospital Process for healing wounds
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
HU193289B (en) * 1984-06-19 1987-09-28 Universal Vegyipari Szoevetkez Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4665054A (en) * 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu

Also Published As

Publication number Publication date
JP2604457B2 (ja) 1997-04-30
EP0314755A1 (en) 1989-05-10
JPH02500367A (ja) 1990-02-08
NO890089L (no) 1989-01-10
NO890089D0 (no) 1989-01-10
NO175616B (es) 1994-08-01
DK10389D0 (da) 1989-01-11
EP0314755B1 (en) 1994-08-24
DK10389A (da) 1989-01-11
KR890701079A (ko) 1989-12-19
DE3851203T2 (de) 1994-12-15
KR960014776B1 (en) 1996-10-19
CA1323839C (en) 1993-11-02
DE3851203D1 (de) 1994-09-29
AU1729688A (en) 1988-12-06
JP2988876B2 (ja) 1999-12-13
US5135913A (en) 1992-08-04
NO175616C (no) 1994-11-09
AU609819B2 (en) 1991-05-09
WO1988008695A1 (en) 1988-11-17
JPH09278631A (ja) 1997-10-28
ATE110255T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
MX169205B (es) Composicion para estimular el crecimiento del cabello
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
DK545584A (da) Enzym-resistente immonumodulatoriske peptider
IE870236L (en) Method for stimulation of melanin production
BR7504001A (pt) Artigos cirurgicos implantaveis,utilizaveis em cirurgia humana ou animal,total ou parcialmente bioresorbaveis
ATE55905T1 (de) Mittel zur behandlung und zum schutz der haut.
IL56149A (en) 13-halo and 13-deoxy derivatives of c-076 compounds,their preparation and method for the treatment of parasitic infections in animals therewith
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
SE8802869D0 (sv) Combination of pyramidine derivatives and retonoids, as separate components, for inducing and stimulating hair growth and reducing its loss
SE8700203L (sv) Pyroglutamidderivat
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE3851456D1 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
ES2058909T3 (es) Agente para el cuidado de uñas, piel y cabello.
DE3373978D1 (en) Composition for the care or treatment of the human skin
ES2018807B3 (es) Procedimiento para curtir el cuero
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
ATE38773T1 (de) Biologisches mittel zur behandlung der haare und der haut.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE3276786D1 (en) Medical process and preparation
IT8220835A0 (it) Preparazione di soluzioni iniettabili di actinina impiegabili nella terapia umana come antalgico per il trattamento del dolore da neoplasie ed altre affezioni.
ATE73731T1 (de) Verbesserung bei der behandlung weicher gewebe.